Monday, September 04, 2017 9:02:43 AM
On February 23, 2017, the Company acquired 4,000,000 shares of common stock of an unrelated public Company for $11,000 in contributed capital. During the year ended February 28, 2017, the Company sold 429,387 shares in this company and recorded gain on sale of marketable securities of $1,617,601.
The Company fair valued the marketable security available for sale at February 28, 2017 (no marketable securities at February 29, 2016) and recorded an unrealized gain on change in fair value of $12,196,847. Subsequent to the year end through the date these financials were issued, the fair value of these securities significantly decreased. The market price of the stock decreased from $3.48 per share as of February 28, 2017 to $0.1 per share as of June 9, 2017.
SIGO Historical Summary
Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week 1.23 1.4 0.567 0.8675 117k 387k 260k -0.34 -27.64%
1 Month 0.4 2.25 0.33 1.1397 116k 697k 372k 0.49 122.50%
3 Months 0.1 2.25 0.1 0.8923 0 697k 175k 0.79 790.00%
6 Months 3.18 3.2 0.064685 0.6406 0 854k 155k -2.29 -72.01%
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM